BRAF V600 Mutation Clinical Trials in London
2 recruitingLondon, United Kingdom
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Colorectal, CancerColorectal CarcinomaNon-small Cell Lung Cancer+29 more
Institut de Recherches Internationales Servier554 enrolled27 locationsNCT05786924
Recruiting
UK ENcorafenib and BInimetinib Real-world Study in Melanoma
Metastatic Melanoma, BRAF V600 Mutation Positive
Pierre Fabre Ltd50 enrolled7 locationsNCT07022457